EA200501088A1 - Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее - Google Patents

Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее

Info

Publication number
EA200501088A1
EA200501088A1 EA200501088A EA200501088A EA200501088A1 EA 200501088 A1 EA200501088 A1 EA 200501088A1 EA 200501088 A EA200501088 A EA 200501088A EA 200501088 A EA200501088 A EA 200501088A EA 200501088 A1 EA200501088 A1 EA 200501088A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cetyl
pharmaceutical compositions
compositions containing
healing agent
pyridine salt
Prior art date
Application number
EA200501088A
Other languages
English (en)
Other versions
EA008003B1 (ru
Inventor
Джорджио Пиффери
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А.
Publication of EA200501088A1 publication Critical patent/EA200501088A1/ru
Publication of EA008003B1 publication Critical patent/EA008003B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Цетилпиридиниевая соль диклофенака.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200501088A 2003-02-14 2004-02-12 Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее EA008003B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000269A ITMI20030269A1 (it) 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio
PCT/EP2004/001412 WO2004072017A1 (en) 2003-02-14 2004-02-12 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it

Publications (2)

Publication Number Publication Date
EA200501088A1 true EA200501088A1 (ru) 2005-12-29
EA008003B1 EA008003B1 (ru) 2007-02-27

Family

ID=32866065

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501088A EA008003B1 (ru) 2003-02-14 2004-02-12 Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее

Country Status (16)

Country Link
US (1) US7250428B2 (ru)
EP (1) EP1592657A1 (ru)
JP (1) JP2006517565A (ru)
KR (1) KR20050101186A (ru)
CN (1) CN1318389C (ru)
AR (1) AR043171A1 (ru)
AU (1) AU2004212154A1 (ru)
CA (1) CA2511900A1 (ru)
EA (1) EA008003B1 (ru)
GE (1) GEP20064009B (ru)
HK (1) HK1080449A1 (ru)
IL (1) IL169312A (ru)
IT (1) ITMI20030269A1 (ru)
MX (1) MXPA05008589A (ru)
PL (1) PL376362A1 (ru)
WO (1) WO2004072017A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2011009010A1 (en) 2009-07-15 2011-01-20 University Of Medicine And Dentistry Of New Jersey Novel compounds for inhibiting eef2 kinase activity
KR101666659B1 (ko) * 2014-06-12 2016-10-14 한국생명공학연구원 부틸 피리디늄 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
IT1228242B (it) * 1986-11-13 1991-06-05 Ricerfarma Srl Milano Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono
IT1250636B (it) 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
ATE268186T1 (de) * 1994-06-06 2004-06-15 Thejmde Trust Biotinverbindungen zum zielen auf tumore und infektionsherde
DE19856101A1 (de) * 1998-12-04 2000-06-08 Labtec Gmbh Mundhöhlen-Matrixpflaster
JP2000256186A (ja) * 1999-03-05 2000-09-19 Taisho Pharmaceut Co Ltd 咽頭疾患用組成物

Also Published As

Publication number Publication date
CN1318389C (zh) 2007-05-30
AR043171A1 (es) 2005-07-20
AU2004212154A1 (en) 2004-08-26
EA008003B1 (ru) 2007-02-27
IL169312A (en) 2010-05-17
GEP20064009B (en) 2006-12-25
EP1592657A1 (en) 2005-11-09
WO2004072017A1 (en) 2004-08-26
KR20050101186A (ko) 2005-10-20
JP2006517565A (ja) 2006-07-27
MXPA05008589A (es) 2005-11-04
HK1080449A1 (zh) 2006-04-28
CN1745061A (zh) 2006-03-08
CA2511900A1 (en) 2004-08-26
ITMI20030269A1 (it) 2004-08-15
PL376362A1 (en) 2005-12-27
IL169312A0 (en) 2007-07-04
US20060142353A1 (en) 2006-06-29
US7250428B2 (en) 2007-07-31

Similar Documents

Publication Publication Date Title
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
EA200301215A1 (ru) Лиганды рецепторов 5-ht и их применение
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA200401204A1 (ru) Сульфонилпроизводные в качестве новых ингибиторов гистон-деацетилазы
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
SE0301653D0 (sv) Novel compounds
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA200401202A1 (ru) Сульфонилпроизводные в качестве новых ингибиторов гистон-деацетилазы
EA200500520A1 (ru) Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов
EA201100689A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
EA200700189A1 (ru) Производные хиназолина в качестве ингибиторов parp
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA200401526A1 (ru) Новые соединения и их применение
BRPI0516981A (pt) inibidores de mif
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
EA200801413A1 (ru) Гетероциклические сетр ингибиторы
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
EA200500528A1 (ru) Пиперазинил- и диазапанилбензамиды и бензтиоамиды

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU